Katiuska Gonzalez, Family Medicine Medicare: Medicare Enrolled Practice Location: 159 Calle Zafra, Urbanizacion El Pedregal, San German, PR 00683 Phone: 305-484-9820 |
Dr. Anibal Rosado Vidro, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Urb.kintas Del Rey G2, San German, PR 00683 Phone: 787-677-0436 Fax: 787-264-7291 |
Dr. Carlos Moises Ramirez-jimenez, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Victoria Esq. Sol #76 Street, San German, PR 00683 Phone: 787-264-2495 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat specialty, critical and orphan central nervous system (CNS) disorders, today announced the successful completion of a $38 million Series C financing. OrbiMed Advisors, LLC, EcoR1 Capital Management, Foresite Capital Management and two undisclosed blue chip public investment funds joined existing investors Third Rock Ventures and ARCH Venture Partners.
A rehabilitation technique originally developed for stroke has now been shown to also be effective for improving function for people with multiple sclerosis, a neurodegenerative disease.
For patients contemplating spinal fusion surgery to alleviate pain, bone health is an important consideration. If a patient is found to have low bone density prior to surgery, it could affect the treatment plan before, during and after the procedure.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
› Verified 8 days ago